~~<i id='A13D5FF715'><strike id='A13D5FF715'><tt id='A13D5FF715'><pre id='A13D5FF715'></pre></tt></strike></i>~~

Home» focus» leisure time

leisure time

author：knowledge 2025-09-06 06:43:15 Page View：4

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Companies helping big Covid
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

comprehensive

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

Watch the official trailer for 'Ahsoka' series

3:52RosarioDawsonasAhsokaTanoinascenefromtheseries"StarWars:Ahsoka."LucasfilmLtd/Disney+Theofficialt

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

One Duchenne patient's bittersweet hope for new treatment

Duchennemusculardystrophyisadevastatingdiseaseand,untilveryrecently,wasonewithoutmuchhope.WhenHawken

WSS

leisure time

leisure time

explore

comprehensive

One Duchenne patient's bittersweet hope for new treatment